Rapid(POC) Molecular Test (RMT) – Testing Guidance v3 Mar 5 2021

Community Support Services EMS Home Care Hospital Indigenous Health Long-Term Care Mental Health & Addictions Primary Care Public Health Retirement Home Other
Labs, Testing & Screening

Summary

  • Document maps out a framework for testing within the following scenarios: Using a Rapid Molecular Test (RMT – e.g., ID NOW) for:
  • Symptomatic individuals
  • Asymptomatic individuals with known contact with a positive COVID-19 case
  • Using a Rapid Antigen Test (RAT – e.g., Panbio, BD Veritor) for
  • Asymptomatic individuals

Actions

  • Rapid Molecular Test (RMT) are ID NOW and GeneXpert
  • Symptomatic individual without known contact with a positive COVID-19 case
  • Any individual (symptomatic or asymptomatic) with known contact with a positive COVID-19 case
  • Asymptomatic individual without known contact with a positive COVID-19 case

DISCLAIMER: This document has been reviewed by Ontario Health West staff. While staff has provided its summary and interpretation of key action items, every health service provider remains responsible for ensuring their own understanding of the document and actions items, next steps and/or accountabilities outlined in the document.

Past Versions

No Past Versions

DD Mmmmmm 2020 – PASTE TITLE HERE